Response Prediction News Today

A secondary analysis found a brain scan with an AI algorithm predicted within a week 1/3 of patients would respond to sertraline and 2/3 would not.

<p>In patients with major depression disorder it is, thanks to use of artificial intelligence, now possible to predict within a week whether an antidepressant will work. With the help of an AI algorithm, a brain scan and an individual's clinical information, researchers from Amsterdam UMC and Radboudumc could see up to 8 weeks faster whether or not the medication would work. The results of this study are published today in the American Journal of Psychiatry.</p>

Toronto, ON (PRWEB) October 12, 2022 -- The failure rate of late-stage oncology clinical trials is one of the highest across therapeutic areas, whereas many

ABBVie will present results from nearly 30 abstracts across eight types of cancer during the upcoming American Society of Hematology Annual Meeting in Atlanta, Georgia . "We are dedicated to transforming standards of care for people living with blood cancers," said Mohamed Zaki M.D., Ph.D, vice president and global head of oncology development, AbbVie. "The data we are presenting at the ASH Annual Meeting build on ...

/PRNewswire/ -- AbbVie (NYSE: ABBV) will present results from nearly 30 abstracts across eight types of cancer during the upcoming American Society of...

The Strategic Imperative Growth Opportunities Fuel the Growth Pipeline Engine 2. Executive Summary Key Findings for the Immuno-oncology Market-Breakthrough Innovations, Program Acceleration, and Smart Production Market Snapshot, Global Immuno-oncology Market Summary of Growth Opportunities-Best Suited Therapy Design Summary of Growth Opportunities-Optimal Path to Market 3. Market Overview-Immuno-oncology 4. Immuno-oncology Value Chain and R&D Expenditure-Immuno-oncology Immuno-oncology Clin...